10x Genomics (TXG) Revenue (2018 - 2026)
10x Genomics (TXG) revenue from Mar 31, 2018 to Mar 31, 2026. The TTM 10x Genomics (TXG) revenue is $639M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
10x Genomics (TXG) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +2.26% |
| 3 Years TTM | +6.01% |
| 5 Years TTM | +13.93% |
| All Time TTM | +18.05% |
Annual Revenue change of 10x Genomics (TXG)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $151M | -76.53% |
| 2025 | $643M | +5.24% |
| 2024 | $611M | -1.28% |
| 2023 | $619M | +19.81% |
| 2022 | $516M | +5.28% |
| 2021 | $490M | +64.13% |
| 2020 | $299M | +21.54% |
| 2019 | $246M | +68.06% |
| 2018 | $146M | +105.84% |
| 2017 | $71M | N/A |
Comparison 10x Genomics (TXG) five years revenue CAGR with competitors
10x Genomics (TXG) five years revenue CAGR is 13.93%.